SNaP®

Spiracur Announces Final Results from Multi-Center Randomized Controlled Clinical Trial

Spiracur Admin — Tue, 08 May 2012 19:22:21 +0000

May 8, 2012– Spiracur® Inc., the developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, today announced the final results of a 17-center prospective randomized-controlled trial evaluating the safety and efficacy of its SNaP® Wound Care System …Continue reading ›

Spiracur Announces Four New Clinical Abstracts Demonstrating the Value of the SNaP® Wound Care System

Spiracur Admin — Fri, 20 Apr 2012 16:02:22 +0000

April 19, 2012– Spiracur® Inc., the developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, today announced four new clinical abstracts demonstrating the efficacy and clinical value of the SNaP® Wound Care System for the treatment of …Continue reading ›

Spiracur Launches New Website Featuring Patient-Friendly Animation

Spiracur Admin — Tue, 27 Mar 2012 20:15:10 +0000

March 27, 2012– Spiracur^® Inc., developer of an utraportable and disposable negative pressure wound therapy (NPWT) device, recently launched a new, enhanced website featuring patient-friendly animation to demonstrate the benefits of the innovative SNaP^® Wound Care System for treatment of chronic and acute wounds.

Spiracur Awarded Three-year New Technology Contract by Novation for Advanced Wound Care Products and Related Accessories

Spiracur — Fri, 16 Dec 2011 18:28:30 +0000

December 16, 2011– Spiracur® Inc., developer of a small, non-powered innovative negative pressure wound therapy (NPWT) device, today announced that it has been awarded a three-year new technology product supplier agreement by Novation, LLC (Irving, TX), the healthcare industry’s leading …Continue reading ›

Spiracur Announces First European Study Evaluating Outcomes for Treatment of Lower Extremity Diabetic, Venous and Mixed Etiology Wounds

Spiracur — Wed, 16 Nov 2011 17:30:16 +0000

November 15, 2011 – Spiracur® Inc., developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, announced today that a prospective study to evaluate outcomes for the treatment of lower extremity diabetic, venous and mixed etiology leg wounds …Continue reading ›

Spiracur Introduces SNaP® BLUE Foam Dressing Kit

Spiracur — Wed, 02 Nov 2011 00:52:23 +0000

Nov. 2, 2011 – Spiracur Inc., developer of the SNaP® Wound Care System, an ultraportable and disposable negative pressure wound therapy (NPWT) device, today announced that it introduced its SNaP® BLUE Foam Dressing Kit at the Symposium on Advanced Wound …Continue reading ›

Spiracur Donates 25 SNaP® Wound Care Systems for UCSF IGOT Use and Training in Tanzania

Spiracur — Wed, 02 Nov 2011 00:51:11 +0000

October 5, 2011 – Spiracur Inc., developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, announced the donation of 25 SNaP^® Wound Care Systems for teaching and use in Tanzania

Multicenter RCT Abstract Highlighting Spiracur’s SNaP® System Wins Highest Scoring Award at Symposium for Advanced Wound Care

Spiracur — Wed, 02 Nov 2011 00:49:39 +0000

Oct. 4, 2011 – The Symposium on Advanced Wound Care (SAWC) has awarded David G. Armstrong, DPM, M.D., Ph.D., et al., the highest scoring abstract in the clinical research category for their poster

Independence Blue Cross To Cover Spiracur’s SNaP® Wound Care System

Spiracur — Mon, 12 Sep 2011 23:54:18 +0000

July 14, 2011 – Spiracur Inc. announced today that Independence Blue Cross (IBC) of Pennsylvania has expanded its coverage policy to include Spiracur’s SNaP^® Wound Care System, effective July 6, 2011.

Health Canada Issues Medical Device License to Spiracur, Inc. For SNaP® Wound Care System

Spiracur — Sun, 11 Sep 2011 23:54:26 +0000

July 12, 2011 – Spiracur Inc. received a medical device license from Health Canada permitting the company to sell its SNaP® Wound Care System (Smart Negative Pressure) throughout the country. Spiracur’s SNaP® System is a clinically proven, non-powered device designed …Continue reading ›